LONGEVIKIN - Trademark Details
Status: 700 - Registered
Serial Number
87455632
Registration Number
5698062
Word Mark
LONGEVIKIN
Status
700 - Registered
Status Date
2019-03-12
Filing Date
2017-05-18
Registration Number
5698062
Registration Date
2019-03-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-07-03
Law Office Assigned Location Code
L70
Employee Name
JACKSON, STEVEN W
Statements
Goods and Services
Natural or synthetically-derived chemical compounds, molecules, ingredients, chemical emissions, electrical emissions, auditory emissions and/or photonic emissions that contribute to the health of an organism. Natural compounds and ingredients prepared from organic sources, namely herbal extracts that serve as anti-inflammatories, such as curcumin from turmeric root, immune boosters such as oleuropein from olive leaf, antioxidants such as resveratrol from red grape skins and adaptogens such as ginsenoside from ginseng show benefits to an organism's health and longevity and are collectively known as Longevekins. Similarly, there are synthetically derived chemical compounds that contribute to health and longevity, namely Metformin or Rapamycin. Chemical molecules include nootropics, namely piracetam and hormone peptides, namely GHRP-6. Chemical emissions include small chain fatty acids, namely butyric acid and hormones, namely HGH (human growth hormone). Electrical emissions, such as PEMF (pulsed electromagnetic field) and Rife frequencies. Auditory emissions such as healing sounds, namely binaural beats and solfeggio frequencies. Photonic emissions, such as organic subtle light forms, namely biophotons and artificially created light, namely 635nm red laser light emissions
Goods and Services
Natural compounds and ingredients prepared from organic sources, namely, herbal extracts for medical purposes that serve as anti-inflammatories, namely, curcumin from turmeric root, immune boosters, namely, oleuropein from olive leaf, antioxidants, namely, resveratrol from red grape skins and adaptogens, namely, ginsenoside from ginseng; metformin and rapamycin
Translation of Words in Mark
The wording "Longevikin" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-05-29
Primary Code
005
First Use Anywhere Date
2007-00-00
First Use In Commerce Date
2007-00-00
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
ASCENDED HEALTH WORLDWIDE LLC
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2017-05-22 | NEW APPLICATION ENTERED IN TRAM |
2017-05-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2017-08-16 | ASSIGNED TO EXAMINER |
2017-08-23 | NON-FINAL ACTION WRITTEN |
2017-08-23 | NON-FINAL ACTION E-MAILED |
2017-08-23 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-01-31 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-01-31 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-02-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-02-22 | FINAL REFUSAL WRITTEN |
2018-02-22 | FINAL REFUSAL E-MAILED |
2018-02-22 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2018-05-29 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2018-05-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-05-29 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-05-30 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-05-29 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2018-06-13 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-07-03 | PUBLISHED FOR OPPOSITION |
2018-07-03 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-08-28 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2018-09-27 | TEAS STATEMENT OF USE RECEIVED |
2018-10-23 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2018-09-27 | USE AMENDMENT FILED |
2018-10-24 | STATEMENT OF USE PROCESSING COMPLETE |
2018-11-15 | SU - NON-FINAL ACTION - WRITTEN |
2018-11-15 | NON-FINAL ACTION E-MAILED |
2018-11-15 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-01-16 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-01-18 | ASSIGNED TO LIE |
2019-01-28 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-01-28 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-02-07 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2019-02-08 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2019-03-12 | REGISTERED-PRINCIPAL REGISTER |